Therapeutic and Aesthetic Uses of Photodynamic Therapy

Part three of a five-part series

by Michael H. Gold, MD

Medical Director, Gold Skin Care Center and The Laser & Rejuvenation Center, Nashville, Tennessee

Read the rest of this article »

This supplement is based on a round table discussion that took place on June 28, 2008, at the Sandestin Beach Hilton Hotel in Sandestin, Florida. Dr. Hebert moderated the discussion. Roundtable participants included Drs. Baum, DelRosso, Dwyer,Eastern, and Herron. This supplement was supported by Graceway Pharmaceuticals and did not undergo peer review by The Journal of Clinical and Aesthetic Dermatology’s
Editorial Advisory Board.

Read the rest of this article »

by Matthew S. Keller, MD; Jason Lee, MD; and Guy F. Webster, MD, PhD
Department of Dermatology, Jefferson Medical College, Philadelphia, Pennsylvania

Disclosure: The authors identified no conflicts of interest.

Read the rest of this article »

by Matthew J. Zirwas, MD, and Sarah A. Stechschulte

Matthew J. Zirwas, MD, is Assistant Professor of Dermatology, The Ohio State University. Sarah A. Stechschulte is a Medical Student, University of Miami Miller School of Medicine. Disclosures: Dr. Zirwas receives honoraria from Coria Laboratories. Ms. Stechschulte reports no relevant conflicts of interest.

Read the rest of this article »

by James Q. Del Rosso, DO; Sanjay Bhambri, DO; and Brent Michaels, DO
Valley Hospital Medical Center, Las Vegas, Nevada

Disclosure: Dr. Del Rosso is a consultant to, speaker for, and performs research for Obagi Medical Products, Arcutis, Allergan, Coria, Galderma, Graceway, Intendis, Medicis, Onset, OrthoNeutrogena, PharmaDerm, Quinnova, Ranbaxy, SkinMedica, Stiefel, Triax, Unilever, and Warner Chilcott. Drs. Bhambri and Michaels identified no conflicts of interest. Read the rest of this article »

by Kathryn E. Boyse, MD, and Matthew J. Zirwas, MD
The Ohio State University Medical Center, Division of Dermatology, Columbus, Ohio

Disclosure: The authors identified no conflicts of interest.

Abstract
Chemical leukoderma is seen in a variety of clinical settings. We present a case of leukoderma associated with the phenolic derivative thymol found in a common over-the-counter medication for nasal congestion. The proposed mechanism for this type of leukoderma is presented along with other sources of phenolic and catecholic derivatives. Treatment is also briefly reviewed.

(J Clin Aesthetic Derm. 2008;1(4):34–35.) Read the rest of this article »

by James Q. Del Rosso, DO, FAOCD

Dr. James Del Rosso, DO, FAOCD, is Dermatology Residency Director, Valley Hospital Medical Center; Clinical Associate Professor (Dermatology), University of Nevada School of Medicine, Las Vegas, Nevada; and Associate Professor (Dermatology), Touro University College of Osteopathic Medicine, Henderson, Nevada.

Read the rest of this article »

Selected Presentations from the 2008 Winter Clinical Dermatology Conference
Held at the Ritz Carlton Kapalua Resort, Maui, Hawaii, March 14–18, 2008
Read the rest of this article »